Disappointment and frustration are perhaps two terms that best describe the tone of Guided Therapeutics' (Norcross, Georgia) conference call revealing the news about the company receiving a not approvable letter from the FDA for its LuViva device.
Nearly every day at MDD we report on the latest advances in health IT, one of the fastest growing sectors in the industry. It seems like new HIT and systems-related companies are cropping up every week, promising to enhance communication between patients and providers, and improve clinical workflow. But what happens when this technology fails – and trust me, it will – and the people trained to use these fancy pants systems are not taught how to go back to the basics, a.k.a. the pen-and-paper method? Let me give you an example from my own recent experience with the military’s...